Search by Drug Name or NDC
NDC 43066-0995-24 Clindamycin phosphate 900 mg/50mL Details
Clindamycin phosphate 900 mg/50mL
Clindamycin phosphate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is CLINDAMYCIN PHOSPHATE.
MedlinePlus Drug Summary
Clindamycin injection is used to treat certain types of bacterial infections, including infections of the lungs, skin, blood, bones, joints, female reproductive organs, and internal organs. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria. Antibiotics such as clindamycin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 43066-0995-24Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clindamycin Injection
Product Information
| NDC | 43066-0995 |
|---|---|
| Product ID | 43066-995_c82b7e0c-b3c4-46ae-a859-aac273937592 |
| Associated GPIs | |
| GCN Sequence Number | 015999 |
| GCN Sequence Number Description | clindamycin phosphate/D5W PIGGYBACK 900MG/50ML INTRAVEN |
| HIC3 | W1K |
| HIC3 Description | LINCOSAMIDE ANTIBIOTICS |
| GCN | 40822 |
| HICL Sequence Number | 004704 |
| HICL Sequence Number Description | CLINDAMYCIN PHOSPHATE/DEXTROSE 5 % IN WATER |
| Brand/Generic | Generic |
| Proprietary Name | Clindamycin phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clindamycin phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 900 |
| Active Ingredient Units | mg/50mL |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208084 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43066-0995-24 (43066099524)
| NDC Package Code | 43066-995-24 |
|---|---|
| Billing NDC | 43066099524 |
| Package | 24 BAG in 1 CASE (43066-995-24) / 50 mL in 1 BAG |
| Marketing Start Date | 2022-02-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |